Antibe Therapeutics Company Top Insiders

ATBPF Stock  USD 0.22  0.00  0.00%   
Antibe Therapeutics employs about 37 people. The company is managed by 9 executives with a total tenure of roughly 87 years, averaging almost 9.0 years of service per executive, having 4.11 employees per reported executive. Examination of Antibe Therapeutics' management performance can provide insight into the company performance.
Philip Stern  Insider
VP Communications
Ana Stegic  Insider
Director Operations
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Antibe Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.

Antibe Therapeutics Management Team Effectiveness

The company has return on total asset (ROA) of (0.1642) % which means that it has lost $0.1642 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.4013) %, meaning that it generated substantial loss on money invested by shareholders. Antibe Therapeutics' management efficiency ratios could be used to measure how well Antibe Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities.

Antibe Therapeutics Workforce Comparison

Antibe Therapeutics is number one stock in number of employees category among its peers. The total workforce of Health Care industry is presently estimated at about 432. Antibe Therapeutics holds roughly 37.0 in number of employees claiming about 9% of equities under Health Care industry.

Antibe Therapeutics Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. Antibe Therapeutics Price Series Summation is a cross summation of Antibe Therapeutics price series and its benchmark/peer.

Antibe Therapeutics Notable Stakeholders

An Antibe Therapeutics stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Antibe Therapeutics often face trade-offs trying to please all of them. Antibe Therapeutics' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Antibe Therapeutics' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Philip SternVP CommunicationsProfile
Ana StegicDirector OperationsProfile
LLB JDCEO and PresidentProfile
MEng CFAChief OfficerProfile
MBA MScFounder ChairProfile
MBA DOChief OfficerProfile
David VaughanChief Devel. OfficerProfile
MBA MBAChief OfficerProfile
Christina BBAVP RelationsProfile

About Antibe Therapeutics Management Performance

The success or failure of an entity such as Antibe Therapeutics often depends on how effective the management is. Antibe Therapeutics management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Antibe management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Antibe management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Antibe Therapeutics Inc., a biotechnology company, engages in developing novel therapeutics and medical devices in the areas of pain, inflammation and regenerative medicine in Canada, Europe, the United States, and internationally. Antibe Therapeutics Inc. was incorporated in 2009 and is headquartered in Toronto, Canada. Antibe Therapeutics is traded on OTC Exchange in the United States.

Antibe Therapeutics Workforce Analysis

Traditionally, organizations such as Antibe Therapeutics use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Antibe Therapeutics within its industry.

Antibe Therapeutics Manpower Efficiency

Return on Antibe Therapeutics Manpower

Revenue Per Employee0.0
Revenue Per Executive0.0
Net Loss Per Employee677.3K
Net Loss Per Executive2.8M
Working Capital Per Employee39.2K
Working Capital Per Executive161K

Complementary Tools for Antibe Pink Sheet analysis

When running Antibe Therapeutics' price analysis, check to measure Antibe Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Antibe Therapeutics is operating at the current time. Most of Antibe Therapeutics' value examination focuses on studying past and present price action to predict the probability of Antibe Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Antibe Therapeutics' price. Additionally, you may evaluate how the addition of Antibe Therapeutics to your portfolios can decrease your overall portfolio volatility.
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Bonds Directory
Find actively traded corporate debentures issued by US companies
Stocks Directory
Find actively traded stocks across global markets
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities